Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Board?
Income Statement
Revenue (ttm): 2.84M
Revenue Per Share (ttm): 0.007
Qtrly Revenue Growth (yoy): 3513.50%
Gross Profit (ttm): 319.41K
EBITDA (ttm): -5.22M
Net Income Avl to Common (ttm): 16.71M
Diluted EPS (ttm): 0.042
Qtrly Earnings Growth (yoy): -34.60%

This is from Yahoo financial. I believe the fact that the revenue line item is always such a measely number to casual lookers, our stock gets passed by. Net income available to Common, is the only place that the PDS earnings show up. A quick glance would tell you this company's revenue doesn't amount to anything..... they must have recieved a one-time payment for something. Snore....

How will this ever change without bringing on a secondary business that shows qtrly. sales?

Share
New Message
Please login to post a reply